HPN 2020 Sept

Page 1

HOSPITAL PROFESSIONAL NEWS IRELAND

HPN September 2020 Issue 76 HOSPITALPROFESSIONALNEWS.IE

Ireland’s Dedicated Hospital Professional Publication

IN THIS ISSUE:

DRIVEN TO FULFIL THE PROMISE OF BIOSIMILARS— THE PFIZER WAY The Pfizer Promise is simple: To help you provide patients with more treatment options while delivering a portfolio of potentially cost saving oncology biosimilars.1-3

Breadth of offerings Pfizer has a portfolio of oncology biosimilars on the market, including both cancer therapies and supportive care products, to give patients more treatment options.2,3

Quality focused Pfizer oncology biosimilars are all produced to meet the same high-quality standards as Pfizer's other biologics—using the same robust protocols for monitoring quality throughout every stage of the manufacturing process.4

Manufacturing and supply experience Pfizer leverages more than 30 years of state-of-the-art manufacturing and supply-chain experience in biologics to reliably deliver biosimilars to patients.4,5

References: 1. IMS Institute for Healthcare Informatics. Delivering on the Potential of Biosimilar Medicines: The Role of Functioning Competitive Markets. Parsippany, NJ: IMS; March 2016. 2. Drugs.com. How many biosimilars have been approved in the United States? https://www.drugs.com/medical-answers/many-biosimilars-approved-united-states-3463281/. Updated December 8, 2019. Accessed July 2020. 3. McGowan S, Jesse M. Biosimilars Pipeline Report. AmerisourceBergen. https:/www.amerisourcebergen.com/-/ media/assets/amerisourcebergen/biosimilars-pipeline-report_0420_v3.pdf?la=en&hash=1071304C7B66ED62628201B8268C0B633 627CB6B. Updated May 1, 2020. Accessed July 2020. 4. Data on file. Pfizer Inc., New York, NY. 5. Pfizer. Heritage in Biologics. https:// www.iononline.com/SiteRepository/Biosimilar/Pfizer/Pfizer-Heritage-in-Biologics_25Oct19. July 2016. Accessed July 2020.

PP-BIO-IRL-0085

All rights reserved.

July 2020

News: Impact of Consultant vacancies evident Page 4 Report: Medicines for Ireland on Lessons from Covid-19 Page 8 Perspectives: Pharmacists on the frontline Page 12 Feature: Changing landscape of secondary cardiovascular prevention in Stroke Page 16 CPD: MS – Now a treatable condition? Page 23 Educational: Increased breast cancer risk in obesity Page 32


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.